StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 5.2
Power Rank trend -> Rising
07/26/2024 16:00:00 EST
Definitive Healthcare Corp (DH)
Industry: Health Information Services
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, DH has been trading in a range between $6.02 and $5.09 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
DH is trading between resistance at $7.86 about 30% to the upside and support at $5.65 -6% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $9.03, about a 50% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
$DH entered a Green zone 5 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $12.45, a potential down side of INF% from the recent price of 0.00. The stock is trading NAN% (potential upside) below its 52 week high of $0.00 and NAN % (potential downside) above its 52 week low of $0.00 - based on the recent price.
Company Summary
Definitive Healthcare Corp, together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
News
| Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. Source: GlobeNewsWire Mon, 22 Jul 2024 16:05:00 -0400 Sentiment: Neutral |
| Baker Tilly and Definitive Healthcare enhance life sciences compliance CHICAGO--(BUSINESS WIRE)--Leading advisory, tax and assurance firm Baker Tilly announces its collaboration with Definitive Healthcare to streamline fair market value (FMV) and key opinion leader (KOL) compliance procedures for life sciences companies. Leveraging Baker Tilly's decades of life sciences industry expertise and Definitive Healthcare's Monocl ExpertData, which facilitates the integration of expert data into internal systems and applications, this collaboration aims to set a new stand. Source: Business Wire Wed, 10 Jul 2024 11:00:00 -0400 Sentiment: Neutral |
| Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devices Source: GlobeNewsWire Tue, 09 Jul 2024 09:47:00 -0400 Sentiment: Neutral |
| Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare's Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare's new Chief Executive Officer and member of the Board, effective June 24, 2024. The awards were granted as an inducement material to Mr. Coop's commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). Source: GlobeNewsWire Tue, 25 Jun 2024 18:57:00 -0400 Sentiment: Neutral |
| Definitive Healthcare Wins 2024 Databricks Healthcare and Life Sciences Partner of the Year Award Empowering healthcare and life science organizations with faster insights through seamless data sharing Empowering healthcare and life science organizations with faster insights through seamless data sharing Source: GlobeNewsWire Tue, 11 Jun 2024 09:15:00 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 11.97 52 Week Low: 4.38 Beta: 1.307 50 Day MA: 5.5434 200 Day MA: 7.4598 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0 Qtr Revenue Growth YOY: 0.072 Forward PE: 19.3424 Trailing PE: 0